Page 30 - Small Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

‘The ketamine blew my mind’: can psychedelics cure addiction and depression? Words: Alexandra Jones Illustration: Frieda Ruh In the summer of 1981, when he was 13, Grant crashed a trail motorbike into a wall at his parents’ house in Cambridgeshire. He’d been hiding it in the shed, but “it was far too powerful for me, and on my very first time starting it in the garden, I smashed it into a wall”. His mother came outside to find the skinny teenager in a heap next to the crumpled motorbike. “I was in a lot of trouble.” Grant hadn’t given this childhood memory mu...

‘The ketamine blew my mind’: can psychedelics cure addiction and depression? ‘We prepare a client for their drug experience; allow them to feel safe and warm.’ Illustration: Frieda Ruh/The Guardian ‘We prepare a client for their drug experience; allow them to feel safe and warm.’ Illustration: Frieda Ruh/The Guardian This week sees the opening of the first UK high-street clinic offering psychedelic-assisted therapy. Could popping psilocybin be the future of mental healthcare? Sat 13 Mar 2021 06.00 EST Last modified on Tue 16 Mar 2021 07.53 EDT In the summer of ...

Pharmaceutical Contract Development and Manufacturing Market worth $146.1 billion by 2025 - Exclusive Report by MarketsandMarkets "Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid, Semi-Solids), End User (Big Pharma, Small Pharma, Generic Pharma,CRO)-Global Forecast to 2025", published by MarketsandMarkets, the global Pharmaceutical Contract Manufacturing Market is projected to reach USD 146.1 billion by 2025 from USD 100.7 billion in 2020, at a CAGR of 7.7% between 2020 and 2025. Browse in-dep...

Alexander_Volkov/Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now. The psychedelics industry has ramped up over the past year as institutional investors entered and several companies have gone public. Insider identified the top 14 startups that are working to turn psychedelics into approved medicines for conditions like depression, opioid use disorder, and anxiety.  To put together this article, we reached out to companies on our list from last year, used data pro...

WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories News provided by Share this article Share this article SHANGHAI, Feb. 24, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that the company has been named a winner of the 2021 CMO Leadership Awards for a fourth year in a row. The company is proud to receive this distinction in all six award categories – capabilities, compatibility, expertise, quality, reliability, and service – and across the three respond...